Vlad Vitoc
Directeur Général chez MAIA BIOTECHNOLOGY, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Dr. Vlad Vitoc is a Chairman, President & Chief Executive Officer at MAIA Biotechnology, Inc. and a Chief Executive Officer & Director at DGD Pharmaceuticals Corp.
He is on the Board of Directors at DGD Pharmaceuticals Corp.
He received his MBA from the University of South Carolina and a doctorate degree from Iuliu Hatieganu University of Medicine & Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
4,95% | 26/04/2024 | 1 019 121 ( 4,95% ) | 3 M $ | 30/04/2024 |
Postes actifs de Vlad Vitoc
| Sociétés | Poste | Début |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Directeur Général | 03/08/2018 |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Directeur Général | - |
Formation de Vlad Vitoc
| University of South Carolina | Masters Business Admin |
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
| MAIA Biotechnology, Inc. |